498
The assessment of adverse effects on the health on professional workers potentially exposed to hazardous substances during their manufacturing has become a key activity for HSE (Health, Safety and Environment) of all chemical (including pharmaceutical) companies since years (at least 15/20). The progressive demand to determine such evaluation is due to many reasons. In particular:
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox
And many other benefits!
Register
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | COLUMN: Regulation
Life Sciences Regulatory experts share predictions for 2023
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | EDITORIAL
EU chemical legislation – Overkill or necessary precaution?
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | CHIRAL TECHNOLOGIES
Contemporary chiral resolutions
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | ADVERTORIAL
Raybow – Why sustainable chemistry is the future of pharma: boos...
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | FLOW CHEMISTRY
Continuous flow photochemistry and green chemistry
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | PROCESS DEVELOPMENT
Transitioning to a circular bioeconomy: Key drivers and the new cluste...
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | HPAPIS
HPAPI Cleaning validation considerations – Part 2
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | A WORD WITH
Tanya Murphy, Associate Director of Compliance at AstraZeneca Lead of...
MAGAZINE
Vol. 41 | Vol. 41(2) - March / April 2023 | REPORT






























